resourcesasterdmhealthcare.com/.../2016/07/output_1467395242.docx · web viewtotal quality...

Created in the cloud with Aspose.Words for Cloud. http://www.aspose.com/cloud/word-api.aspx

Resources Loading...Publications Logos Health Watch Magazine Health Reach Newsletter

World Heart Day - Health Reach 95Download

Back to School Health Reach Issue 94Download

DBS Surgery at Aster Medcity Kochin - English VersionDownload

Health Watch Issue - 23Download

Health Watch - Issue 22Download

Ms. Alisha Moopens Interview in Femina Middle eastDownload

Express HealthcareDownload

Aster DM HealthcareDownload

AsterDownload

Aster HospitalDownload

Aster ClinicDownload

Aster PharmacyDownload

MedcareDownload

Medcare Medical CentreDownload

Access ClinicDownload

Access PharmacyDownload

Aster MedcityDownload

Aster MIMSDownload

DM WIMSDownload

Aster Aadhar hospitalDownload

Aster CMI HospitalDownload

Aster Prime HospitalDownload

Aster Medcare HospitalDownload

Group Health Watch Issue 24Download

Summer Tips - Your Skin Your CareDownload

Health Reach Issue 91- Preparing for RamadanDownload

Health Reach issue 89 - Start your stop smoking Plan nowDownload

Health Reach Issue - 89 World Asthma DayDownload

Health Reach- Is your Risk Higher than You ThinkDownload

Health Reach – Back to SchoolDownload

Health Reach – Ways to Sleep BetterDownload

Health Reach – RamadanDownload

Health Reach – No Tobacco DayDownload

Health Reach – World Asthma DayDownload

Health Reach – World Health DayDownload

Health Reach – Women's DayDownload

Health Reach – World Arthritis DayDownload

Health Reach – Breast Cancer Awareness DayDownload

Health Reach – World Heart DayDownload

Health Reach – Medical Myths BustedDownload

Health Reach – Ramadan EditionDownload

Health Reach – SinusitisDownload

Health Reach – Back to School EditionDownload

Health Reach – Women's Day SpecialDownload

Health Reach – PimplesDownload

Health Reach – New Year SpecialDownload

Health Reach – World Health DayDownload

Health Reach – Heart Day PledgeDownload

Health Reach – Health Tips for SummerDownload

Health Reach – Health During HolidaysDownload

Health Reach – Living With DiabetesDownload

Health Reach – Dry Winter WeatherDownload

Health Reach - Breast Cancer AwarenessDownload

Health Watch – Issue 12Download

Dr Azad Moopen - Gulf Yearbook 2015Download

Dr Azad Moopen - Power Letters 2016 - Gulf BusinessDownload

Aster DM Healthcare - Calendar 2016Download

Ms Alisha Moopen - Aster invests Dh3bn in GCC Healthcare - Gulf PropertyDownload

Dr Azad Moopen - CEO Gold Stars - CEO Middle EastDownload

Aster Hospital - Interior Magazine (Malayalam) - Jan 2016Download

Dr Harish Pillai's column in Health Biz India - Jan 2016Download

Health Reach 96Download

Health Watch - Issue 25Download Show All

Chairman's Message In Pursuit of Providing Quality Healthcare that is Affordable and Accessible

Click here to view Dr. Azad Moopen’s Profile

We have been consistent in our mission to provide quality healthcare at affordable cost at the door steps of people we serve, ever since we started the journey of “Caring Mission with a Global Vision” 3 decades back. This rhymes well with the universal healthcare philosophy of Quality, Affordability and Accessibility.

In the area of Quality we can showcase umpteen awards and certificates proving our credentials, but more importantly it runs deeper in the DNA of Aster DM Healthcare. Our teams drive the quality program as the corner stone with a strong belief that there is no finishing line in the race for excellence.

Healthcare worldwide is becoming more and more expensive, but we try to make our services Affordable. Healthcare, though deemed as an ‘industry’ is much more than that – we strongly believe that profit should be a byproduct and not the aim in healthcare, which helps us to transcend into our core values, of Compassion, Integrity and Respect. In an exercise to serve all sections of the society, we have rolled out different brands with varying price bands. We also provide support to those who are in need through our Foundations and CSR activities.

Accessibility to healthcare services is a very important focus area for us – we provide services closer to our customers through the large network of clinics and pharmacies – however, this is only like touching the tip of the iceberg. We are in the process of rolling out programs, leveraging Information Technology to make accessibility much wider and deeper, carrying delivery of healthcare to the homes of people.

We have recently adopted the byline “We’ll Treat You Well”. This is actually a promise to all our internal and external stakeholders, which include our partners, employees, patients, business associates and public. From top down, we promise our internal stakeholders that we’ll treat everyone well.Then as Asterians, we sing a chorus to our external stake holders that we’ll treat them well.

Many ask me the recipe for our success – from a single doctor clinic in Dubai to a network of 280 establishments, spread in 9 countries with over 13000 staff as of 31st March, 2016. I strongly believe that it has been due to the blessings of the God and the support of the visionary leaders and people of the countries we operate and the hard work of the united and passionate team of Asterians.

Dr. Azad Moopen, MDFounder Chairman & Managing DirectorAster DM Healthcare

Vision Values and Mission A PROMISE OF EXCELLENCE, ETHOS TO LIVE BY

VISION

“A Caring Mission with a Global Vision”

VALUES

ExcellenceSurpassing current benchmarks constantly by continually challenging our ability and skills to take the organization to greater heights

CompassionGoing beyond boundaries with empathy and care

IntegrityDoing the right thing without any compromise and embracing a higher standard of conduct.

RespectTreating people with utmost dignity, valuing their contributions and fostering a culture that allows each individual to rise to their fullest potential

PassionGoing the extra mile willingly, with a complete sense of belongingness and purpose while adding value to all our stakeholders.

UnityHarnessing the power of synergy and engaging people for exponential performance and results.

OUR PROMISE

“We’ll Treat You Well”

A promise that sums up what we do and why we exist. One that we strive to honor every day, every moment.

Quality Policy QUALITY POLICY

At Aster DM Healthcare, we subscribe to the view that quality is the outcome of all activities that take place within the organization. Total Quality Management (TQM), a discipline and philosophy of management which institutionalizes planned and continuous improvement is instituted in our group. We also place emphasis on the focus of improvements being on systems and processes rather than on the individual; also that all function and employees have to participate in the improvement process.

SCOPE

At Aster DM Healthcare, we subscribe to the view that quality is the outcome of all activities that take place within the organization. Total Quality Management (TQM), a discipline and

philosophy of management which institutionalizes planned and continuous improvement is instituted in our group. We also place emphasis on the focus of improvements being on systems and processes rather than on the individual; also that all function and employees have to participate in the improvement process.

GOALS AND OBJECTIVES

To promote a safe environment for patients and staff to facilitate a culture of quality throughout all organizations in the group To provide a systematic approach to performance improvement activities To promote high quality, cost effective services through the development and implementation of policies, procedures and guidelines.Promote effective communication. Foster staff education processes. Improve employee relations and promote employee satisfaction. Ensure all DOHMS and other regulatory requirements are included in performance measures. Establish priorities for performance improvement activities

CLIENT COMPLAINTS

To manage and use client feedback data through complaints and surveys for continuous quality improvement

QUALITY EDUCATION AND TRAINING

To promote quality education and training initiatives for the staff

QUALITY CULTURE

To develop a culture of continuous improvement across the organization

QUALITY MODEL

The Aster DM Healthcare Quality Model focuses on the customer (be they internal or external customers), supported by structures, processes and outcomes.

METHODOLOGY

Find Organize Clarify Uncover Start Plan Do Check Act (FOCUS-PDCA) Model: Whenever staff are engaged in performance improvement and patient safety initiatives, they must begin by listening to all customers (the voice of the consumer), focus on the processes that these customers experience (the voice of the process), and then use statistical process control methods to evaluate the variation that lives within the processes.

Code of Conduct ASTER DM HEALTHCARE LIMITED

The members of the Board of Directors of Aster DM Healthcare Limited acknowledge and accept the scope and extent of their duties as Directors. They have a responsibility to carry out their duties in an honest and businesslike manner and within the scope of their authority, as set forth in the laws of India as well as in the Memorandum and Articles of Association of the Company. They are entrusted with and are responsible for the oversight of the assets and business affairs of Aster DM Healthcare Limited in an honest, fair, diligent and ethical manner. As Directors, they must act within the bounds of the authority conferred upon them and with the duty to make and enact informed decisions and policies in the best interests of the Company. The Board of Directors has adopted the following Code of Conduct and the Directors and senior managers are expected to adhere to the standards of care, loyalty, good faith and the avoidance of conflicts of interest that follow.

Code of Conduct

Board Members and senior managers will:

Act in the best interests of, and fulfill their fiduciary obligations to the Company; Act honestly, fairly, ethically and with integrity; Conduct themselves in a professional, courteous and respectful manner and not take

improper advantage of their position; Will deal fairly with all stakeholders; Comply with all applicable laws, rules and regulations; Act in good faith, responsibly, with due care, competence and diligence, without allowing

their independent judgment to be subordinated; Not use the Company’s property or position for personal gain; Will not accept from or give to stakeholders gifts or other benefits not customary in

normal social intercourse; Not use any information or opportunity received by them in their capacity as Directors or

senior management in a manner that would be detrimental to the Company’s interests; Act in a manner to enhance and maintain the reputation of the Company; Disclose any personal interest that they may have regarding any matters that may come

before the Board and abstain from discussion, voting or otherwise influencing a decision on any matter in which the concerned Director has or may have such an interest;

Abstain from discussion, voting or otherwise influencing a decision on any matters that may come before the board in which they may have a conflict or potential conflict of interest;

Not to serve as a Director or otherwise be in employment or engage in providing services to a Company that competes with the Company.

Respect the confidentiality of information relating to the affairs of the Company acquired in the course of their service as Directors or senior management, except when authorized or legally required to disclose such information;

Not use confidential information acquired in the course of their service as Directors or senior management for their personal advantage or for the advantage of any other entity;

Help create and maintain a culture of high ethical standards and commitment to Compliance;

In addition to the above mentioned general code of conduct, Independent Directors on the Board of Directors of the Company shall:-

Undertake appropriate induction and regularly update and refresh their skills,knowledge and familiarity with the company;

Seek appropriate clarification or amplification of information and, where necessary, take and follow appropriate professional advice and opinion of outside experts at the expense of the company;

Strive to attend all meetings of the Board of Directors and of the Board committees of which he is a member;

Participate constructively and actively in the committees of the Board in which they are chairpersons or members;

Strive to attend the general meetings of the company; Where they have concerns about the running of the company or a proposed action, ensure

that these are addressed by the Board and, to the extent that they are not resolved, insist that their concerns are recorded in the minutes of the Board meeting;

Keep themselves well informed about the company and the external environment in which it operates;

Not to unfairly obstruct the functioning of an otherwise proper Board or committee of the Board;

Pay sufficient attention and ensure that adequate deliberations are held before approving related party transactions and assure themselves that the same are in the interest of the company;

Ascertain and ensure that the company has an adequate and functional vigil mechanism and to ensure that the interests of a person who uses such mechanism are not prejudicially affected on account of such use;

Report concerns about unethical behaviour, actual or suspected fraud or violation of the company’s code of conduct or ethics policy;

Acting within his authority, assist in protecting the legitimate interests of the company, shareholders and its employees;

Not disclose confidential information, including commercial secrets, technologies, advertising and sales promotion plans, unpublished price sensitive information, unless such disclosure is expressly approved by the Board or required by law.

A Director or senior manager who has concerns regarding compliance with this Code should raise those concerns with the Chairman of the Board and the Chairman of the Audit Committee, who will determine what action shall be taken to deal with the concern. In the extremely unlikely event that a waiver of this Code for a Director would be in the best interest of the Company, it must be approved by the Audit Committee and the Board of Directors.

There may be situations in which a Director would be in breach of his duty of confidentiality to another entity were he to disclose a conflict of interest to the Board of the Company. In such a situation, it shall be sufficient for the Director concerned to abstain from any participation in the matter concerned, without disclosing the nature of the conflict.

WhistleBlower ASTER DM HEALTHCARE LIMITED

Preface

The Aster DM Healthcare Limited (“Aster DM”) believes in the conduct of the affairs of its constituents in a fair and transparent manner by adopting highest standards of professionalism, honesty, integrity and ethical behaviour.

Section 177 of the Companies Act, 2013 (“Act”) requires every listed company and such class or classes of companies, as may be prescribed, shall establish a vigil mechanism for directors and employees to report genuine concerns in such manner as may be prescribed.

Accordingly, this Whistle Blower Policy (“the Policy”) has been formulated with a view to provide a mechanism for employees of the Company to approach the Audit Committee of the Company and genuine concerns which affect the Company.

Definitions

The definitions of some of the key terms used in this Policy are given below. Capitalised terms not defined herein shall have the meaning assigned to them under the Code.

“Audit Committee” means the Audit Committee constituted by the Board of Directors of the Company in accordance with Section 177 of the Companies Act, 2013.

“Employee” means every employee of the Company (whether working in India or abroad), including the Directors in the employment of the Company.

“Investigators” or “the Investigator” mean those person(s) authorised, appointed, consulted or approached by the Audit Committee and includes the auditors of the Company and the police.

“Protected Disclosure” means any communication made in good faith that discloses or demonstrates information that may evidence unethical or improper activity.

“Aster DM” or “the Company” means Aster DM Healthcare Limited “Subject” means a person against or in relation to whom a Protected Disclosure has been

made or evidence gathered during the course of an investigation. “Whistle Blower” means an Employee making a Protected Disclosure under this Policy.

Scope

The Whistle Blower’s role is that of a reporting party with reliable information. They are not required or expected to act as investigators or finders of facts, nor would they determine the appropriate corrective or remedial action that may be warranted in a given case.

Whistle Blowers should not act on their own in conducting any investigative activities, nor do they have a right to participate in any investigative activities other than as requested by the Investigator or the Audit Committee or the Investigators.

Protected Disclosure will be appropriately dealt with by the Audit Committee.

Eligibility

All Employees of the Company are eligible to make Protected Disclosures under the Policy. The Protected Disclosures may be in relation to matters concerning the Company.

Disqualifications

While it will be ensured that genuine Whistle Blowers are accorded complete protection from any kind of unfair treatment as herein set out, any abuse of this protection will warrant disciplinary action.

Protection under this Policy would not mean protection from disciplinary action arising out of false or bogus allegations made by a Whistle Blower knowing it to be false or bogus or with a mala fide intention.

Whistle Blowers, who make three or more Protected Disclosures, which have been subsequently found to be mala fide, frivolous, baseless, malicious, or reported otherwise than in good faith, will be disqualified from reporting further Protected Disclosures under this Policy. In respect of such Whistle Blowers, the Company/Audit Committee would reserve its right to take/recommend appropriate disciplinary action.

Procedure

All Protected Disclosures should be addressed to the Chairman of the Audit Committee of the Company.The contact details of the Chairman of the Audit Committee are as under:

The Chairman,Audit CommitteeAster DM Healthcare LimitedAster Medcity, Kuttisahib RoadNear Kothad Bridge, South Chittoor P OCheranalloor, Kochi, [email protected]

Protected Disclosures should preferably be reported in writing so as to ensure a clear understanding of the issues raised and should either be typed or written in a legible handwriting in English, Hindi or in the regional language of the place of employment of the Whistle Blower.

The Protected Disclosure should be forwarded under a covering letter which shall bear the identity of the Whistle Blower. The Chairman of the Audit Committee shall detach the covering letter and discuss the Protected Disclosure with Members of the Audit Committee and if deemed fit, forward the Protected Disclosure to the Investigator of the Company for investigation.

Protected Disclosures should be factual and not speculative or in the nature of a conclusion, and should contain as much specific information as possible to allow for proper assessment of the nature and extent of the concern and the urgency of a preliminary investigative procedure.

The Whistle Blower must disclose his/her identity in the covering letter forwarding such Protected Disclosure. Anonymous disclosures will not be entertained by the Audit Committee as it would not be possible for it to interview the Whistle Blowers.

Investigation

All Protected Disclosures reported under this Policy will be thoroughly investigated by the Investigator of the Company who will investigate / oversee the investigations under the authorisation of the Audit Committee.

Protected Disclosures involving or relating to the Investigator which in the opinion of the Audit Committee may hamper the independence of the Investigator in conducting the investigation will be investigated by the Audit Committee itself.

The Investigator / Audit Committee may at its discretion, consider involving any Investigators for the purpose of investigation.

The decision to conduct an investigation taken by the Audit Committee is by itself not an accusation and is to be treated as a neutral fact-finding process. The outcome of the investigation may not support the conclusion of the Whistle Blower that an improper or unethical act was committed.

The identity of a Subject will be kept confidential to the extent possible given the legitimate needs of law and the investigation.

Subjects will normally be informed of the allegations at the outset of a formal investigation and have opportunities for providing their inputs during the investigation.

Subjects shall have a duty to co-operate with the Investigator / Audit Committee or any of the Investigators during investigation to the extent that such co-operation sought does not merely require them to admit guilt.

Subjects have a right to consult with a person or persons of their choice, other than the Investigator / Investigators and/or members of the Audit Committee and/or the Whistle Blower. Subjects shall be free at any time to engage counsel at their own cost to represent them in the investigation proceedings.

Subjects have a responsibility not to interfere with the investigation. Evidence shall not be withheld, destroyed or tampered with, and witnesses shall not be influenced, coached, threatened or intimidated by the Subjects.

Unless there are compelling reasons not to do so, Subjects will be given the opportunity to respond to material findings contained in an investigation report. No allegation of wrongdoing against a Subject shall be considered as maintainable unless there is good evidence in support of the allegation.

Subjects have a right to be informed of the outcome of the investigation. If allegations are not sustained, the Subject should be consulted as to whether public disclosure of the investigation results would be in the best interest of the Subject and the Company.

The investigation shall be completed normally within 45 days of the receipt of the Protected Disclosure.

Protection

No unfair treatment will be meted out to a Whistle Blower by virtue of his/her having reported a Protected Disclosure under this Policy. The Company, as a policy, condemns any kind of discrimination, harassment, victimization or any other unfair employment practice being adopted against Whistle Blowers. Complete protection will, therefore, be given to Whistle Blowers against any unfair practice like retaliation, threat or intimidation of termination/suspension of service, disciplinary action, transfer, demotion, refusal of promotion, or the like including any direct or indirect use of authority to

obstruct the Whistle Blower’s right to continue to perform his duties/functions including making further Protected Disclosure. The Company will take steps to minimize difficulties, which the Whistle Blower may experience as a result of making the Protected Disclosure. Thus, if the Whistle Blower is required to give evidence in criminal or disciplinary proceedings, the Company will arrange for the Whistle Blower to receive advice about the procedure, etc.

The identity of the Whistle Blower shall be kept confidential to the extent possible and permitted under law. Whistle Blowers are cautioned that their identity may become known for reasons outside the control of the Investigator /Audit Committee (e.g. during investigations carried out by Investigators).

Any other Employee assisting in the said investigation shall also be protected to the same extent as the Whistle Blower.

Investigators

Investigators are required to conduct a process towards fact-finding and analysis. Investigators shall derive their authority and access rights from the Audit Committee when acting within the course and scope of their investigation.

Technical and other resources may be drawn upon as necessary to augment the investigation. All Investigators shall be independent and unbiased both in fact and as perceived. Investigators have a duty of fairness, objectivity, thoroughness, ethical behavior, and observance of legal and professional standards.

Investigations will be launched only after a preliminary review which establishes that: o The alleged act constitutes an improper or unethical activity or conduct, ando Either the allegation is supported by information specific enough to be

investigated, or matters that do not meet this standard may be worthy of management review, but investigation itself should not be undertaken as an investigation of an improper or unethical activity.

Decision

If an investigation leads the Audit Committee to conclude that an improper or unethical act has been committed, the Audit Committee shall direct the management of the Company to take such disciplinary or corrective action as the Audit Committee deems fit. It is clarified that any disciplinary or corrective action initiated against the Subject as a result of the findings of an investigation pursuant to this Policy shall adhere to the applicable personnel or staff conduct and disciplinary procedures.

Reporting

The Investigator shall submit a report to the Audit Committee on a regular basis about all Protected Disclosures referred to him/her since the last report together with the results of investigations, if any.

Retention of documents

All Protected Disclosures in writing or documented along with the results of investigation relating thereto shall be retained by the Company for a minimum period of seven years.

Amendment

The Company reserves its right to amend or modify this Policy in whole or in part, at any time without assigning any reason whatsoever. However, no such amendment or modification will be binding on the Employees unless the same is notified to the Employees in writing.

Management A synergy of thought and action, propelled by a passionate team leads to excellence

Dr. Azad MoopenChairman & Managing Director

Dr. Azad Moopen, 63, is the Chairman and Managing Director of our Company. He is a gold medalist in Medicine and a post graduate in General Medicine from University of Calicut, Kerala, India and a diploma holder in Tuberculosis and Chest Diseases from Delhi University, Delhi, India. He is responsible for our Company’s overall business operations and is responsible for setting forth the group strategy and vision. He also serves as a director of NORKA Roots and the Kerala State Industrial Development Corporation. He has set up Dr. Moopen’s Foundation, a charitable foundation for extending healthcare charitable benefits to the less privileged. He has been a Director of our Company since its incorporation. He has been honoured by the Government of India with the Padma Shri Award in 2011 and the Pravasi Bharatiya Samman in 2010. He has also been conferred the Best Doctor Award by the Government of Kerala in 2009. He has also received the Arab Health Award from the Arab Health Forum in 2010, the Arabian Business Achievement Award from the ITP Publishing Group in 2010 and the Healthcare CEO of the Year Award at the CEO Middle East Awards 2015.

T.J WilsonExecutive Director & Group Head – Governance & Corporate Affairs

T. J. Wilson, 55, is a Director of our Company and the Group Head – Goveranance and Corporate Affairs, GCC. He holds a bachelor’s degree in Commerce from the University of Calicut, Kerala, India. He is also a member of the Institute of Chartered Accountants of India. In the past, he has worked with Koyenco Feeds Private Limited and Parle (Exports) Limited. He is responsible for overseeing the legal, secretarial and governance function, Saudi vertical, internal audit and large portfolio of new hospital projects. He has been a Director of our Company since April 20, 2009.

Alisha MoopenExecutive Director & CEO – Hospitals & Clinics GCC

Alisha Moopen, 34, is a Director of our Company and the Chief Executive Officer – Hospitals & Clinics, GCC. She holds a bachelor’s degree in Business Administration from the University of Michigan, Ann Abor. She is a member of the Institute of Chartered Accountants of Scotland. She has previously worked at Ernst and Young LLP. She is experienced in the field of finance and administration. She is responsible for overseeing the strategy of the group. She has been a Director of our Company since September 20, 2013

Sreenath P. ReddyGroup Chief Financial Officer (CFO)

Sreenath Reddy, 42, is the group chief financial officer. He was appointed to this post on November 15, 2012. He is a member of the Institute of Chartered Accountants of India, and holds a bachelor’s degree in Commerce and a bachelor’s degree in Law, both from the Bangalore University, Bangalore, India. He is experienced in the field of accounts and finance. Prior to joining our Company he was working as the chief financial officer of Narayana Hrudalaya Limited.

Ala AttariVP & CEO – Medcare Hospitals and Clinics

Ala Atari, 49, is the chief executive officer of our hospitals operated under the ‘Medcare’ brand. He joined our group on November 25, 2006. He holds a bachelor’s degree in Science (Health Administration) from Warren National University, USA. He has also completed a technologist course in Nuclear Medicine from the Nuclear Medicine Institute, University of Findlay, USA, and a certificate programme in Business Administration from Tulane University, USA. He is responsible for the administration of our Medcare hospitals.

Dr. Harish PillaiCluster Head for Kerala & CEO – Aster Medcity

Dr. Harish Pillai, 48, is the chief executive officer – Aster Medcity, Kochi and cluster head – Kerala. He was appointed toas the chief executive officer – Aster Medcity, Kochi with effect from May 27, 2013 and was appointed as cluster head – Kerala on September 20, 2015 with effect from August 1, 2015. He holds a bachelor’s degree in Medicine and Surgery from the University of Mangalore, India, a masters’ degree in Hospital Management from Osmania University, Hyderabad, India and a masters’ degree in Business Administration in International Hospital and Healthcare Management from the Frankfurt School of Finance and Management, Frankfurt, Germany. He is

experienced in the healthcare sector. He is responsible for the operations and business of Aster Medcity, Kochi. Prior to joining Aster Medcity, Kochi, he worked as the chief executive officer of As Salam International Hospital, Cairo, Egypt. He has also worked with Apollo Hospitals Enterprises Limited in the past.

Jobilal M. VavachanAVP & CEO – Aster PharmacyJobilal M. Vavachan, 45, is the assistant vice president and chief executive officer of our Aster Pharmacies. He joined the group on July 14, 2005. He holds a bachelor’s degree in Pharmacy from Bangalore University, Bangalore, India. He is experienced in the field of pharmacy retailing. He is responsible for the administration of our Aster Pharmacies.

RatneshGroup Chief Human Resources Officer (CHRO)

Ratnesh, 43, is the chief human resource officer of our group. He was appointed to this post on April 21, 2015. He holds aBachelor’s degree in Arts from the University of Delhi. Prior to joining DM Healthcare LLC, he has worked at Fortis Healthcare International Pte Limited, Infosys Limited and Moser Baer India Limited.

Dr. A. MalathiGroup Chief Quality Officer & Chief Medical Officer (GCC)

Dr. A. Malathi, 62, is the chief quality officer of our group. She was appointed to this post on February 16, 2015. She holdsa bachelor’s degree in Medicine and Surgery from Bangalore University and a master’s degree in Human Physiology from Bombay University. She has also completed a training programme in hospital administration from the Tata Institute of Social Sciences. She is experienced in the field of healthcare. Prior to joining Dr. Moopen’s Healthcare Management Services LLC, she has worked at Fortis Hospitals Limited, Manipal Health Enterprises Private Limited and Lokmanya Tilak Municipal Medical College.

Mukta AroraGroup Chief Information Officer (CIO)

Mukta Arora, 51 is the chief information officer of the group. She joined our group on January 19, 2016. She holds a postgraduate diploma in Business Management from the Birla Institute of Management Technology. Prior to joining Dr. Moopen’s Healthcare Management Services LLC, she worked as the vice-president at HCL Technologies Limited and Nucleus Software Exports Limited. She has also worked at Perot Systems TSI (India) Limited, Computer Science Corporation Limited and El Moisheer Hospital, KSA.

Kartik ThakrarFinancial Controller – GCC

Kartik Thakrar, 41, is the financial controller of our operations in the GCC States. He was promoted as finance controlleron December 20, 2012. He has completed the intermediate examination conducted by the Institute of Chartered Accountants of India. He is experienced in the field of healthcare services. He is responsible for strategic decisions including project feasibility, business acquisitions, capital investments, internal process and systems review, development of new business models and investor relations.

Prof. K.K. VarmaGroup Chief Medical Officer

K. K. Varma, 75, is the group chief medical officer. He was appointed to this post with effect from November 1, 2015. Hehas been with the group since September 3, 2001. He holds a master’s degree in Surgery from the University of Kerala,Faculty of Medicine. He is also a fellow of the Royal Australasian College of Surgeons. He is experienced in the field ofhealthcare.

Karthik RajagopalChief Executive Officer – Aster Hospitals & Clinics, GCC

Karthik Rajagopal, 46 is the chief executive officer – Aster Hospitals and Clinics. He was appointed to this post witheffect from February 17, 2016. He holds a bachelor’s degree in Commerce from Bharathidasan University, a master’s degree in Management from Asian Institute of Management, Manila and has completed the Executive General Management Programme from the Indian Institute of Management, Bangalore. He is experienced in the field of healthcare. He is responsible for the overall operations of Aster Hospitals and Clinics in GCC. Prior to joining DM Healthcare LLC, he worked as the regional director at Fortis Healthcare Limited and Lanka Hospitals. He has also worked at Fortis Hospitals Limited, Wockhardt Hospitals Limited, Apollo Hospitals and Manipal Healthcare Private Limited in the past.

Rajesh ACompany Secretary

Rajesh A., 30, is the Company Secretary of our Company. He was appointed to this post with effect from April 29, 2013.He has been admitted as a fellow of the Institute of Company Secretaries of India. He holds a bachelor’s degree inCommerce from Mahatma Gandhi University, Kerala, India. Prior to joining our Company he was working as a companysecretary with Muthoot Finance Limited.

Dialysis Centres Dialysis Centres

In India, our MIMS hospital provides subsidized dialysis to patients in need of treatment, and the MIMS Charitable Trust operates a rural health centre.

Read more…

resourcesasterdmhealthcare.com/.../2016/07/output_1467395242.docx · web viewtotal quality...

Documents